Polypharmacy in palliative care: optimising medications is an ongoing challenge.

Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12269

Full metadata record

DC Field	Value	Language
dc.contributor.author	Charlton, S	-
dc.contributor.author	Le, B H C	-
dc.date.accessioned	2015-05-16T01:55:48Z
dc.date.available	2015-05-16T01:55:48Z
dc.date.issued	2014-06-01	-
dc.identifier.citation	Internal Medicine Journal; 44(6): 619-20	en
dc.identifier.other	PUBMED	en
dc.identifier.uri	https://ahro.austin.org.au/austinjspui/handle/1/12269	en
dc.language.iso	en	en
dc.subject.other	Cardiovascular Diseases	en
dc.subject.other	Female	en
dc.subject.other	Humans	en
dc.subject.other	Hypolipidemic Agents.therapeutic use	en
dc.subject.other	Male	en
dc.subject.other	Palliative Care.methods	en
dc.subject.other	Terminally Ill.statistics & numerical data	en
dc.title	Polypharmacy in palliative care: optimising medications is an ongoing challenge.	en
dc.type	Journal Article	en
dc.identifier.journaltitle	Internal Medicine Journal	en
dc.identifier.affiliation	Palliative Care	en
dc.identifier.doi	10.1111/imj.12451	en
dc.description.pages	619-20	en
dc.relation.url	https://pubmed.ncbi.nlm.nih.gov/24946823	en
dc.type.content	Text	en
dc.type.austin	Journal Article	en
item.openairetype	Journal Article	-
item.cerifentitytype	Publications	-
item.grantfulltext	none	-
item.fulltext	No Fulltext	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.languageiso639-1	en	-
Appears in Collections:	Journal articles

16

checked on Nov 27, 2024

Check